1. Home
  2. AKRO vs RKT Comparison

AKRO vs RKT Comparison

Compare AKRO & RKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKRO
  • RKT
  • Stock Information
  • Founded
  • AKRO 2017
  • RKT 1985
  • Country
  • AKRO United States
  • RKT United States
  • Employees
  • AKRO N/A
  • RKT N/A
  • Industry
  • AKRO Biotechnology: Pharmaceutical Preparations
  • RKT Finance: Consumer Services
  • Sector
  • AKRO Health Care
  • RKT Finance
  • Exchange
  • AKRO Nasdaq
  • RKT Nasdaq
  • Market Cap
  • AKRO 2.2B
  • RKT 2.3B
  • IPO Year
  • AKRO 2019
  • RKT 2020
  • Fundamental
  • Price
  • AKRO $29.53
  • RKT $12.45
  • Analyst Decision
  • AKRO Strong Buy
  • RKT Sell
  • Analyst Count
  • AKRO 8
  • RKT 11
  • Target Price
  • AKRO $46.83
  • RKT $14.36
  • AVG Volume (30 Days)
  • AKRO 535.2K
  • RKT 2.7M
  • Earning Date
  • AKRO 11-08-2024
  • RKT 11-12-2024
  • Dividend Yield
  • AKRO N/A
  • RKT N/A
  • EPS Growth
  • AKRO N/A
  • RKT N/A
  • EPS
  • AKRO N/A
  • RKT N/A
  • Revenue
  • AKRO N/A
  • RKT $4,304,653,000.00
  • Revenue This Year
  • AKRO N/A
  • RKT $15.88
  • Revenue Next Year
  • AKRO N/A
  • RKT $34.83
  • P/E Ratio
  • AKRO N/A
  • RKT N/A
  • Revenue Growth
  • AKRO N/A
  • RKT 13.77
  • 52 Week Low
  • AKRO $15.32
  • RKT $10.87
  • 52 Week High
  • AKRO $37.00
  • RKT $21.38
  • Technical
  • Relative Strength Index (RSI)
  • AKRO 46.87
  • RKT 29.92
  • Support Level
  • AKRO $28.45
  • RKT $12.06
  • Resistance Level
  • AKRO $31.41
  • RKT $14.00
  • Average True Range (ATR)
  • AKRO 1.29
  • RKT 0.45
  • MACD
  • AKRO -0.15
  • RKT -0.05
  • Stochastic Oscillator
  • AKRO 37.64
  • RKT 7.14

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

About RKT Rocket Companies Inc.

Rocket Companies is a financial services company that was originally founded as Rock Financial in 1985 and is currently based in Detroit. Rocket Companies offers a wide array of services and products but is best known for its Rocket Mortgage business. The company's mortgage lending operations are split between its direct-to-consumer lending, which sees borrowers accessing the company's lending arm directly through either its mobile app or website, and its partner network where mortgage brokers and other firms use Rocket's origination process to offer loans to their customers. The company has rapidly gained market share in recent years and is now the largest mortgage originator in the U.S. as well as the servicer for more than 2 million loans.

Share on Social Networks: